A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
Clinical trial NCT05624918 · RECRUITING
Trial details
- NCT number
- NCT05624918
- Sponsor
- Ashish Manne
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2027-08-29
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.